Dr. AYSEN TIMURAGAOGLU

• 1995 – 2012Akdeniz University Faculty of Medicine
• 2006Professor
• 2000 – 2006Associate professor
• 2002University of Wales College of Medicine, Dept of Haematology Cardiff/ England (use of molecular techniques in haematology)
• 1995 – 2000Assistant Professor
• 1995Istanbul University Istanbul Faculty of Medicine Hematology
• 1992Şişli Etfal Training and Research Hospital Internal Medicine
• 1985Ankara University Faculty of Medicine

Experience

• 2022Acıbadem Health Group
• 2016 – 2021Responsible physician of the Hematology and Stem Cell Transplantation Unit of Hisar Intercontinental Hospital
• 2012 – 2016Establishment of EMSEY Hospital Hematology and Stem Cell Transplantation Unit and Responsible Physician
• 1995 – 2012Akdeniz University Faculty of Medicine Lecturer
• 1985 – 1987Compulsory Service

• European Haematology Association
• Hemapheresis Association
• Blood Centers and Transfusion Association
• Turkish Hematology Association
• Istanbul Medical Chamber

• Ionizing Radiation Exposure due to Medical Imaging in Hematopoietic Stem Cell Transplant RecipientsIstanbul Medical Journal, 23(2), 119-124., Doi: 10.4274/imj.galenos.2022.40771 Aksoy SH, Yurdaışık I, Timurağaoğlu A.
• The Efficacy and Safety of Busulfan-Etoposide-Melphalan Regimen in Autologous Stem Cell Transplantation in Relapsed/ Refractory Hodgkin and Non-Hodgkin Lymphoma Patients: ?A Single-Center Experienceİstanbul Med J 2021; 22: 133-9. Eser A, Timurağaoğlu A.
• Prognostic Value of Lenalidomide Maintenance Therapy in Patients with Newly Diagnosed Multiple Myeloma; Single Center Experience-Retrospective StudyVan Medical Journal, 28: 221-226, 2021. A. Eser, A. Timurağaoğlu.
• The Efficacy of Eltrombopag Treatment in Patients who developed Platelet Engraftment Failure after Allogeneic Stem Cell Transplantation: A Single Center Experience.Bezmialem Science, 9: 98-105, 2021. A. Eser, A. Timuragaoglu.
• Effect of single agent bortezomib as post-transplant consolidation therapy on multiple myeloma related bone disease: a randomized phase II studyBr J of Hematol 2017; 178 : 61–71. Sezer O, Beksac M, Hajek R, Sucak G, Cagirgan S, Linkesch W, Meltem Akay O, Gülbas Z, Nahi H, Plesner T, Snowden JA, Timurağaoğlu A, Dechow T, Lang A,
• The role of the nurses and technicians for stem cell mobilisation and collectionTransfusion Apher Sci. 2015;53:30-3. Epub 2015 Jun 29. A. Timurağaoğlu.
• The effect of trans-resveratrol on platelet-neutrophil complex formation and neutrophil burst in hypercholesterolemic ratsExp Clin Cardiol. 2013;18: e 111-4. Göçmen AY, Burgucu D, Karadoğan I, Timurağaoğlu A, Gümüşlü S.
• Aberrations of Chromosomes 9 and 22 in Acute Lymphoblastic Leukemia Cases Detected by ES-Fluorescence In Situ HybridizationGenet Test Mol Biomarkers. 2012 May;16:318-23. Epub 2012 Feb 23. Cetin Z, Yakut S, Karadogan I, Kupesiz A, Timuragaoglu A, Salim O, Tezcan G, Alanoglu G, Ozbalci D, Hazar V, Yesilipek MA, Undar L, Luleci G, Berker S
• The association between inherited thrombophilias and pregnancy-related hypertension recurrence.Arch Gynecol Obstet. 2011 Oct; 284: Epub 2010 Nov 12837-41. Mendilcioglu I, Bilgen T, Arikan Y, Keser I, Simsek M, Timuragaoglu A.
• Listeria monocytogenes meningitis after allogeneic bone marrow transplantation in a patient with MDS-RAEBJ Med Sci 30: 1399-1401, 2010. E. Alkan, A. Timuragaoglu, R. Saba, D. Ogunch.